BIOCommon stockNYSE
BIO Common stock
This is the ticker-level security page. The issuer is Bio-Rad Laboratories.
Security details
Issuer financial context
These figures belong to the issuer company, not to this security itself.
Revenue TTM
$2.6B
Net income TTM
$1.6B
Total assets
$9.7B
Total debt
$1.2B
Total equity
$6.7B
Profit margin
Not available
ROE
23%
ROA
16%
Latest issuer financial snapshot: 2024-12-31